TY - JOUR
AU - S. A. Nowak
AU - V. S. Harder
AU - A. C. Villanti
AU - S. H. Heil
AU - S. C. Sigmon
A1 - 
AD - From the Department of Pathology and Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT (SAN); Department of Pediatrics, Larner College of Medicine at the University of Vermont, Burlington, VT (VSH); Department of Psychiatry, Larner College of Medicine at the University of Vermont, Burlington, VT (VSH); Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Burlington, VT (ACV); Departments of Psychiatry and Psychological Science, University of Vermont, Burlington, VT (SHH); and Departments of Psychiatry and Psychological Science, University of Vermont, Burlington, VT (SCS).
AN - 37934542
BT - J Addict Med
C5 - Opioids & Substance Use; Financing & Sustainability; Healthcare Disparities
CP - 6
DA - Nov-Dec 01
DO - 10.1097/adm.0000000000001208
DP - NLM
ET - 20230818
IS - 6
JF - J Addict Med
LA - eng
PY - 2023
SN - 1932-0620
SP - 714
EP - 716+
ST - Statewide Trends in Buprenorphine Prescribing in Rural and Nonrural Vermont: Analysis of Population-based Patient Pharmacy Claims
T1 - Statewide Trends in Buprenorphine Prescribing in Rural and Nonrural Vermont: Analysis of Population-based Patient Pharmacy Claims
T2 - J Addict Med
TI - Statewide Trends in Buprenorphine Prescribing in Rural and Nonrural Vermont: Analysis of Population-based Patient Pharmacy Claims
U1 - Opioids & Substance Use; Financing & Sustainability; Healthcare Disparities
U3 - 10.1097/adm.0000000000001208
VL - 17
VO - 1932-0620
Y1 - 2023
ER -